chr19-39173042-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005884.5(PAK4):c.329G>A(p.Arg110His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000135 in 1,548,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005884.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAK4 | NM_005884.5 | c.329G>A | p.Arg110His | missense_variant | 4/10 | ENST00000360442.8 | NP_005875.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAK4 | ENST00000360442.8 | c.329G>A | p.Arg110His | missense_variant | 4/10 | 5 | NM_005884.5 | ENSP00000353625.3 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152122Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000120 AC: 18AN: 149598Hom.: 0 AF XY: 0.000125 AC XY: 10AN XY: 80060
GnomAD4 exome AF: 0.000140 AC: 195AN: 1396730Hom.: 0 Cov.: 33 AF XY: 0.000147 AC XY: 101AN XY: 688944
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.329G>A (p.R110H) alteration is located in exon 5 (coding exon 2) of the PAK4 gene. This alteration results from a G to A substitution at nucleotide position 329, causing the arginine (R) at amino acid position 110 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at